Filing Details
- Accession Number:
- 0000899243-15-005453
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-28 17:30:35
- Reporting Period:
- 2015-09-25
- Filing Date:
- 2015-09-28
- Accepted Time:
- 2015-09-28 17:30:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1641489 | Vtv Therapeutics Inc. | VTVT | Pharmaceutical Preparations (2834) | 473916571 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1275756 | G Paul Savas | C/O Vtv Therapeutics Inc. 4170 Mendenhall Oaks Pkwy High Point NC 27265 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2015-09-25 | 5,000 | $6.62 | 20,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $6.415 to $6.685, inclusive. The reporting person undertakes to provide to vTv Therapeutics Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote to this Form 4.
Billionaire Hedge Funds
